Instem plc Director/PDMR Dealings (3441T)
July 17 2020 - 4:15AM
UK Regulatory
TIDMINS
RNS Number : 3441T
Instem plc
17 July 2020
Instem plc
("Instem" or the "Company")
Director/PDMR Dealings
Instem (AIM: INS.L), a leading provider of IT solutions to the
global life sciences market, confirms the following dealings in
Ordinary Shares by certain of the Company's Directors (each of whom
is a PDMR) and, where relevant, their PCAs as outlined below. These
dealings are further to the Company's announcement made on 26 June
2020 regarding the proposed Placing which completed this
morning:
No. of
Ordinary No. of No. of
Shares options Ordinary Resulting
held prior over Ordinary Shares number As a %
to the Shares sold in of Ordinary of Enlarged
Director/PDMR Placing exercised the Placing Shares Share Capital
David Gare and his
wife (via the DG
2008 Discretionary
Settlement) 578,427 - (40,000) 538,427 2.6%
------------ ------------- ---------------
Phil Reason 685,287 187,427 (142,000) 730,714 3.6%
------------ ------------- ------------- ---------------
David Sherwin 1,180,066 - (430,066) 750,000 3.7%
------------ --------------- ------------- ------------- ---------------
Capitalised terms used in this announcement shall, unless
defined in this announcement or unless the context provides
otherwise, bear the same meaning ascribed to such terms in the in
the Circular and Notice of General Meeting dated 30 June 2020, a
copy of which is available to view on the Company's website at
https://investors.instem.com/news/articles/0620-publication-of-circular.php
.
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Peter Steel
Rachel Hayes
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by over 500 customers worldwide,
including all the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services now address aspects of the entire
drug development value chain, from discovery through to market
launch. Management estimate that over 50% of all drugs on the
market have been through some part of Instem's platform at some
stage of their development.
To learn more about Instem solutions and its mission, please visit www.instem.com .
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name David Gare and his wife (via the DG
2008 Discretionary Settlement)
--------------------------------------- --------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------------------------
a) Position / status Non-Executive Chairman
--------------------------------------- --------------------------------------------
b) Initial notification Initial Notification
/ Amendment
--------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------------------
a) Name Instem plc
--------------------------------------- --------------------------------------------
b) LEI 213800PILYUFNNROQX68
--------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument
, type of instrument
GB00B3TQCK30
Identification code
--------------------------------------- --------------------------------------------
b) Nature of the transaction Sale of ordinary shares
--------------------------------------- --------------------------------------------
c) Price(s) and volume(s) Price Volume
--------------------------------------- ------------------------- -----------------
435 pence 40,000
---------------------------------------------------------------------- -----------------
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
--------------------------------------- --------------------------------------------
e) Date of the transaction 17 July 2020
--------------------------------------- --------------------------------------------
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
--------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Phil Reason
-------------------------- ----------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------
a) Position / status Chief Executive Officer
-------------------------- ----------------------------------------------
b) Initial notification Initial Notification
/ Amendment
-------------------------- ----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------------
a) Name Instem plc
-------------------------- ----------------------------------------------
b) LEI 213800PILYUFNNROQX68
-------------------------- ----------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
--------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument
, type of instrument
GB00B3TQCK30
Identification code
-------------------------- ----------------------------------------------
b) Nature of the transaction 1. Exercise of options over Ordinary
Shares
2. Sale of Ordinary Shares
-------------------------- ----------------------------------------------
c) Price(s) and volume(s) Price Volume
-------------------------- ------------------------ --------------------
1. 175 pence 1. 187,427
2. 435 pence 2. 142,000
-------------------------- ------------------------ --------------------
d) Aggregated information n/a - the exercise of options over Ordinary
Shares and the sale of Ordinary Shares
- Aggregated volume each completed as single transactions
- Price
-------------------------- ----------------------------------------------
e) Date of the transaction 17 July 2020
-------------------------- ----------------------------------------------
f) Place of the transaction In respect of the exercise of options
over Ordinary Shares: outside a trading
venue
In respect of the sale of Ordinary Shares:
London Stock Exchange, AIM Market (XLON)
-------------------------- ----------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name David Sherwin
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
a) Position / status Non-Executive Director
-------------------------------------- --------------------------------------------
b) Initial notification Initial Notification
/ Amendment
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
a) Name Instem plc
-------------------------------------- --------------------------------------------
b) LEI 213800PILYUFNNROQX68
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------------------
a) Description of the Ordinary shares of 10 pence each
financial instrument
, type of instrument
GB00B3TQCK30
Identification code
-------------------------------------- --------------------------------------------
b) Nature of the transaction Sale of Ordinary Shares
-------------------------------------- --------------------------------------------
c) Price(s) and volume(s) Price Volume
-------------------------------------- ------------------------ ------------------
435 pence 430,066
-------------------------------------------------------------------- ------------------
d) Aggregated information N/A - single transaction
- Aggregated volume
- Price
-------------------------------------- --------------------------------------------
e) Date of the transaction 17 July 2020
-------------------------------------- --------------------------------------------
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
-------------------------------------- --------------------------------------------
Name of authorised official of issuer responsible for making
notification:
Nigel Goldsmith
Company Secretary to Instem plc
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHKKOBDFBKKQOD
(END) Dow Jones Newswires
July 17, 2020 04:15 ET (08:15 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Instem (LSE:INS)
Historical Stock Chart
From Jul 2023 to Jul 2024
